Please assess the completion status of the following clinical trial:

Trial Title: Cancer End Of Life Evaluation

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* Palliative advanced cancer patient (Palliative chemotherapy, analgesic radiotherapy, surgery of comfort accepted).~* All cancer locations and cancer type~* Patient having the knowledge of their palliative disease stage.~* Patient follow-up at least once a month by a palliative caregiver.~* Age \> or = 18 years.~* Dated and signed consent.~* PS \> or = 2~* Life expectation \> or = 1 month.~Exclusion Criteria:~* Psychiatric Disease or cognitive disorders disrupting the trial understanding and the enlightened and voluntary consent character.~* Patient who can not submit itself to the formal follow-up for psychological, social, family or geographical reasons

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Arm A (Type: EXPERIMENTAL): Patients will complete QoL questionnaires in the following order :~MVQOLI, then QLQ-C15-PAL, then QUAL-E, evaluation every month until death
- Arm B (Type: EXPERIMENTAL): Patients will complete QoL questionnaires in the following order :~QLQ-C15-PAL, then MVQOLI, then QUAL-E, evaluation every month until death
- Arm C (Type: EXPERIMENTAL): Patients will complete QoL questionnaires in the following order :~MVQOLI, then QLQ-C15-PAL, then QUAL-E, evaluation every month and spontaneous QoL completion, until death
- Arm D (Type: EXPERIMENTAL): Patients will complete QoL questionnaires in the following order :~QLQ-C15-PAL, then MVQOLI, then QUAL-E, evaluation every month and spontaneous QoL completion, until death.

Based on this trial design, predict the completion outcome and termination type (if applicable).